Plasmacytoma — Trials

Plasmacytoma — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06863584	SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial	recruiting	Phase 2	41	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Mar 7, 2025	clinicaltrials
NCT05248633	Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma	recruiting	Phase 2	220	Peking Union Medical College HospitalOTHER	1	Jun 5, 2024	clinicaltrials